References
1. JOHANNES C, et al. Risk of Severe Complications of Urinary Tract Infection in Real-World Use of Dapagliflozin. 81st Annual Scientific Sessions of the American Diabetes Association : abstr. 805-P, 25 Jun 2021. Available from: URL: https://eventpilot.us/web/page.php?nav=false&page=IntHtml&project=ADA21&id=407&plannersession=true
2. JOHANNES C, et al. Risk of Acute Liver Injury in Real-World Use of Dapagliflozin. 81st Annual Scientific Sessions of the American Diabetes Association : abstr. 806-P, 25 Jun 2021. Available from: URL: https://eventpilot.us/web/page.php?nav=false&page=IntHtml&project=ADA21&id=24&plannersession=true
Rights and permissions
About this article
Cite this article
Dapagliflozin does not increase risk of severe UTIs or acute liver injury. Reactions Weekly 1868, 8 (2021). https://doi.org/10.1007/s40278-021-00465-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-00465-8